{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T20:51:49Z","timestamp":1761598309338,"version":"3.37.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,2,21]],"date-time":"2021-02-21T00:00:00Z","timestamp":1613865600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,21]],"date-time":"2021-02-21T00:00:00Z","timestamp":1613865600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s00280-021-04243-z","type":"journal-article","created":{"date-parts":[[2021,2,21]],"date-time":"2021-02-21T03:02:41Z","timestamp":1613876561000},"page":"701-710","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Early myelostimulation in patients with locally advanced gastric cancer after fluorouracil plus platinum-based neoadjuvant chemotherapy is related to poor prognosis"],"prefix":"10.1007","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0410-0888","authenticated-orcid":false,"given":"Yang","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongde","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leting","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7123-7983","authenticated-orcid":false,"given":"Haijiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,21]]},"reference":[{"key":"4243_CR1","unstructured":"Cancer statistics.WHO, GLOBOCAN 2018 Stomach. https:\/\/gco.iarc.fr\/today\/data\/factsheets\/cancers\/7-Stomach-fact-sheet.pdf. Accessed 19 Sept 2020"},{"issue":"2","key":"4243_CR2","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1158\/1078-0432.CCR-05-1963","volume":"12","author":"H Yokoyama","year":"2006","unstructured":"Yokoyama H, Nakanishi H, Kodera Y, Ikehara Y, Ohashi N, Ito Y, Koike M, Fujiwara M, Tatematsu M, Nakao A (2006) Biological significance of isolated tumor cells and micrometastasis in lymph nodes evaluated using a green fluorescent protein-tagged human gastric cancer cell line. Clin Cancer Res 12(2):361\u2013368. https:\/\/doi.org\/10.1158\/1078-0432.CCR-05-1963","journal-title":"Clin Cancer Res"},{"issue":"13","key":"4243_CR3","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1200\/JCO.2010.33.0597","volume":"29","author":"M Ychou","year":"2011","unstructured":"Ychou M, Boige V, Pignon JP, Conroy T, Bouche O, Lebreton G, Ducourtieux M, Bedenne L, Fabre JM, Saint-Aubert B, Geneve J, Lasser P, Rougier P (2011) Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. J Clin Oncol 29(13):1715\u20131721. https:\/\/doi.org\/10.1200\/JCO.2010.33.0597","journal-title":"J Clin Oncol"},{"issue":"10","key":"4243_CR4","doi-asserted-by":"publisher","first-page":"691","DOI":"10.2165\/00002018-200326100-00003","volume":"26","author":"PJ Carey","year":"2003","unstructured":"Carey PJ (2003) Drug-induced myelosuppression: diagnosis and management. Drug Saf 26(10):691\u2013706. https:\/\/doi.org\/10.2165\/00002018-200326100-00003","journal-title":"Drug Saf"},{"issue":"9","key":"4243_CR5","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/S1470-2045(05)70255-2","volume":"6","author":"M Di Maio","year":"2005","unstructured":"Di Maio M, Gridelli C, Gallo C, Shepherd F, Piantedosi FV, Cigolari S, Manzione L, Illiano A, Barbera S, Robbiati SF, Frontini L, Piazza E, Ianniello GP, Veltri E, Castiglione F, Rosetti F, Gebbia V, Seymour L, Chiodini P, Perrone F (2005) Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trials. Lancet Oncol 6(9):669\u2013677. https:\/\/doi.org\/10.1016\/S1470-2045(05)70255-2","journal-title":"Lancet Oncol"},{"issue":"1","key":"4243_CR6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/sj.bjc.6603831","volume":"97","author":"T Yamanaka","year":"2007","unstructured":"Yamanaka T, Matsumoto S, Teramukai S, Ishiwata R, Nagai Y, Fukushima M (2007) Predictive value of chemotherapy-induced neutropenia for the efficacy of oral fluoropyrimidine S-1 in advanced gastric carcinoma. Br J Cancer 97(1):37\u201342. https:\/\/doi.org\/10.1038\/sj.bjc.6603831","journal-title":"Br J Cancer"},{"issue":"12","key":"4243_CR7","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1245\/s10434-010-1362-z","volume":"17","author":"K Washington","year":"2010","unstructured":"Washington K (2010) 7th edition of the AJCC cancer staging manual: stomach. Ann Surg Oncol 17(12):3077\u20133079. https:\/\/doi.org\/10.1245\/s10434-010-1362-z","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"4243_CR8","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, Rubinstein L, Shankar L, Dodd L, Kaplan R, Lacombe D, Verweij J (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45(2):228\u2013247. https:\/\/doi.org\/10.1016\/j.ejca.2008.10.026","journal-title":"Eur J Cancer"},{"issue":"9255","key":"4243_CR9","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","volume":"357","author":"F Balkwill","year":"2001","unstructured":"Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357(9255):539\u2013545. https:\/\/doi.org\/10.1016\/S0140-6736(00)04046-0","journal-title":"Lancet"},{"issue":"11","key":"4243_CR10","doi-asserted-by":"publisher","first-page":"e493","DOI":"10.1016\/S1470-2045(14)70263-3","volume":"15","author":"CI Diakos","year":"2014","unstructured":"Diakos CI, Charles KA, McMillan DC, Clarke SJ (2014) Cancer-related inflammation and treatment effectiveness. Lancet Oncol 15(11):e493-503. https:\/\/doi.org\/10.1016\/S1470-2045(14)70263-3","journal-title":"Lancet Oncol"},{"issue":"7","key":"4243_CR11","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s40265-018-0909-3","volume":"78","author":"PM Kasi","year":"2018","unstructured":"Kasi PM, Grothey A (2018) Chemotherapy-induced neutropenia as a prognostic and predictive marker of outcomes in solid-tumor patients. Drugs 78(7):737\u2013745. https:\/\/doi.org\/10.1007\/s40265-018-0909-3","journal-title":"Drugs"},{"issue":"6","key":"4243_CR12","doi-asserted-by":"publisher","first-page":"dju124","DOI":"10.1093\/jnci\/dju124","volume":"106","author":"AJ Templeton","year":"2014","unstructured":"Templeton AJ, McNamara MG, Seruga B, Vera-Badillo FE, Aneja P, Ocana A, Leibowitz-Amit R, Sonpavde G, Knox JJ, Tran B, Tannock IF, Amir E (2014) Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst 106(6):dju124. https:\/\/doi.org\/10.1093\/jnci\/dju124","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"4243_CR13","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/bjc.2013.330","volume":"109","author":"GJ Guthrie","year":"2013","unstructured":"Guthrie GJ, Roxburgh CS, Farhan-Alanie OM, Horgan PG, McMillan DC (2013) Comparison of the prognostic value of longitudinal measurements of systemic inflammation in patients undergoing curative resection of colorectal cancer. Br J Cancer 109(1):24\u201328. https:\/\/doi.org\/10.1038\/bjc.2013.330","journal-title":"Br J Cancer"},{"issue":"4","key":"4243_CR14","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1002\/cam4.1308","volume":"7","author":"Y Wang","year":"2018","unstructured":"Wang Y, Chen Y, Yin H, Gu X, Shi Y, Dai G (2018) Timing of chemotherapy-induced neutropenia is a prognostic factor in patients with advanced gastric cancer undergoing first-line chemotherapy with oxaliplatin and capecitabine: a retrospective study. Cancer Med 7(4):997\u20131005. https:\/\/doi.org\/10.1002\/cam4.1308","journal-title":"Cancer Med"},{"issue":"7","key":"4243_CR15","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nrc.2016.52","volume":"16","author":"SB Coffelt","year":"2016","unstructured":"Coffelt SB, Wellenstein MD, de Visser KE (2016) Neutrophils in cancer: neutral no more. Nat Rev Cancer 16(7):431\u2013446. https:\/\/doi.org\/10.1038\/nrc.2016.52","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"4243_CR16","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1007\/s10120-016-0642-0","volume":"20","author":"Y Choi","year":"2017","unstructured":"Choi Y, Kim JW, Nam KH, Han SH, Kim JW, Ahn SH, Park DJ, Lee KW, Lee HS, Kim HH (2017) Systemic inflammation is associated with the density of immune cells in the tumor microenvironment of gastric cancer. Gastric Cancer 20(4):602\u2013611. https:\/\/doi.org\/10.1007\/s10120-016-0642-0","journal-title":"Gastric Cancer"},{"issue":"5","key":"4243_CR17","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646\u2013674. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013","journal-title":"Cell"},{"issue":"1","key":"4243_CR18","doi-asserted-by":"crossref","first-page":"230","DOI":"10.4049\/jimmunol.134.1.230","volume":"134","author":"HT Petrie","year":"1985","unstructured":"Petrie HT, Klassen LW, Kay HD (1985) Inhibition of human cytotoxic T lymphocyte activity in vitro by autologous peripheral blood granulocytes. J Immunol (Baltimore, Md: 1950) 134(1):230\u2013234","journal-title":"J Immunol (Baltimore, Md: 1950)"},{"issue":"7","key":"4243_CR19","first-page":"2406","volume":"139","author":"A Hag","year":"1987","unstructured":"Hag A, Clark RA (1987) Immunosuppression by activated human neutrophils. Dependence on the myeloperoxidase system. J Immunol (Baltimore, Md: 1950) 139(7):2406\u20132413","journal-title":"J Immunol (Baltimore, Md: 1950)"},{"issue":"12","key":"4243_CR20","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1001\/archsurg.134.12.1325","volume":"134","author":"M McCourt","year":"1999","unstructured":"McCourt M, Wang JH, Sookhai S, Redmond HP (1999) Proinflammatory mediators stimulate neutrophil-directed angiogenesis. Arch Surg (Chicago, Ill: 1960) 134(12):1325\u20131331. https:\/\/doi.org\/10.1001\/archsurg.134.12.1325 ((discussion 1331\u20131322))","journal-title":"Arch Surg (Chicago, Ill: 1960)"},{"key":"4243_CR21","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1159\/000071561","volume":"83","author":"E Di Carlo","year":"2003","unstructured":"Di Carlo E, Forni G, Musiani P (2003) Neutrophils in the antitumoral immune response. Chem Immunol Allergy 83:182\u2013203. https:\/\/doi.org\/10.1159\/000071561","journal-title":"Chem Immunol Allergy"},{"issue":"4","key":"4243_CR22","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1053\/ejso.2001.1133","volume":"27","author":"M McCourt","year":"2001","unstructured":"McCourt M, Wang JH, Sookhai S, Redmond HP (2001) Activated human neutrophils release hepatocyte growth factor\/scatter factor. Eur J Surg Oncol 27(4):396\u2013403. https:\/\/doi.org\/10.1053\/ejso.2001.1133","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"4243_CR23","first-page":"63","volume":"49","author":"E Jab\u0142o\u0144ska","year":"2001","unstructured":"Jab\u0142o\u0144ska E, Kiluk M, Markiewicz W, Piotrowski L, Grabowska Z, Jab\u0142o\u0144ski J (2001) TNF-alpha, IL-6 and their soluble receptor serum levels and secretion by neutrophils in cancer patients. Archivum immunologiae et therapiae experimentalis 49(1):63\u201369","journal-title":"Archivum immunologiae et therapiae experimentalis"},{"issue":"3","key":"4243_CR24","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/ijc.10775","volume":"103","author":"H Schaider","year":"2003","unstructured":"Schaider H, Oka M, Bogenrieder T, Nesbit M, Satyamoorthy K, Berking C, Matsushima K, Herlyn M (2003) Differential response of primary and metastatic melanomas to neutrophils attracted by IL-8. Int J Cancer 103(3):335\u2013343. https:\/\/doi.org\/10.1002\/ijc.10775","journal-title":"Int J Cancer"},{"issue":"2","key":"4243_CR25","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/jcp.10014","volume":"189","author":"P Shamamian","year":"2001","unstructured":"Shamamian P, Schwartz JD, Pocock BJ, Monea S, Whiting D, Marcus SG, Mignatti P (2001) Activation of progelatinase A (MMP-2) by neutrophil elastase, cathepsin G, and proteinase-3: a role for inflammatory cells in tumor invasion and angiogenesis. J Cell Physiol 189(2):197\u2013206. https:\/\/doi.org\/10.1002\/jcp.10014","journal-title":"J Cell Physiol"},{"issue":"11","key":"4243_CR26","doi-asserted-by":"publisher","first-page":"5798","DOI":"10.4049\/jimmunol.168.11.5798","volume":"168","author":"P Scapini","year":"1950","unstructured":"Scapini P, Nesi L, Morini M, Tanghetti E, Belleri M, Noonan D, Presta M, Albini A (1950) Cassatella MA (2002) Generation of biologically active angiostatin kringle 1\u20133 by activated human neutrophils. J Immunol (Baltimore, Md: 1950) 168(11):5798\u20135804. https:\/\/doi.org\/10.4049\/jimmunol.168.11.5798","journal-title":"J Immunol (Baltimore, Md: 1950)"},{"key":"4243_CR27","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.3389\/fimmu.2019.01710","volume":"10","author":"Z Granot","year":"2019","unstructured":"Granot Z (2019) Neutrophils as a therapeutic target in cancer. Front Immunol 10:1710. https:\/\/doi.org\/10.3389\/fimmu.2019.01710","journal-title":"Front Immunol"},{"key":"4243_CR28","doi-asserted-by":"publisher","unstructured":"Best MG, Sol N, In 't Veld S, Vancura A, Muller M, Niemeijer AN, Fejes AV, Tjon Kon Fat LA, Huis In 't Veld AE, Leurs C, Le Large TY, Meijer LL, Kooi IE, Rustenburg F, Schellen P, Verschueren H, Post E, Wedekind LE, Bracht J, Esenkbrink M, Wils L, Favaro F, Schoonhoven JD, Tannous J, Meijers-Heijboer H, Kazemier G, Giovannetti E, Reijneveld JC, Idema S, Killestein J, Heger M, de Jager SC, Urbanus RT, Hoefer IE, Pasterkamp G, Mannhalter C, Gomez-Arroyo J, Bogaard HJ, Noske DP, Vandertop WP, van den Broek D, Ylstra B, Nilsson RJA, Wesseling P, Karachaliou N, Rosell R, Lee-Lewandrowski E, Lewandrowski KB, Tannous BA, de Langen AJ, Smit EF, van den Heuvel MM, Wurdinger T (2017) Swarm intelligence-enhanced detection of non-small-cell lung cancer using tumor-educated platelets. Cancer Cell 32(2):238\u2013252.e239. https:\/\/doi.org\/10.1016\/j.ccell.2017.07.004","DOI":"10.1016\/j.ccell.2017.07.004"},{"issue":"9","key":"4243_CR29","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1038\/nm755","volume":"8","author":"R Okamoto","year":"2002","unstructured":"Okamoto R, Yajima T, Yamazaki M, Kanai T, Mukai M, Okamoto S, Ikeda Y, Hibi T, Inazawa J, Watanabe M (2002) Damaged epithelia regenerated by bone marrow-derived cells in the human gastrointestinal tract. Nat Med 8(9):1011\u20131017","journal-title":"Nat Med"},{"key":"4243_CR30","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.120974","author":"HA Knaus","year":"2018","unstructured":"Knaus HA, Berglund S, Hackl H, Blackford AL, Zeidner JF, Montiel-Esparza R, Mukhopadhyay R, Vanura K, Blazar BR, Karp JE, Luznik L, Gojo I (2018) Signatures of CD8+ T cell dysfunction in AML patients and their reversibility with response to chemotherapy. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.120974","journal-title":"JCI Insight"},{"issue":"5","key":"4243_CR31","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.immuni.2020.04.009","volume":"52","author":"AS Ireland","year":"2020","unstructured":"Ireland AS, Oliver TG (2020) Neutrophils create an ImpeNETrable shield between tumor and cytotoxic immune cells. Immunity 52(5):729\u2013731. https:\/\/doi.org\/10.1016\/j.immuni.2020.04.009","journal-title":"Immunity"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-021-04243-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-021-04243-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-021-04243-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T16:40:41Z","timestamp":1697906441000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-021-04243-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,21]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["4243"],"URL":"https:\/\/doi.org\/10.1007\/s00280-021-04243-z","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"type":"print","value":"0344-5704"},{"type":"electronic","value":"1432-0843"}],"subject":[],"published":{"date-parts":[[2021,2,21]]},"assertion":[{"value":"13 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None of the authors have a relevant financial relationship with a commercial interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions. The exemption from informed consent requirement was permitted by The Affiliated Cancer Hospital of Xinjiang Medical University Institutional Review Board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}